Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
myocarditis [2022/01/04 22:15] brian [COVID-19 Pandemic and Vaccines] | myocarditis [2022/10/09 21:14] (current) pamela [Myocarditis During the COVID-19 Pandemic] | ||
---|---|---|---|
Line 2: | Line 2: | ||
**Myocarditis** is a condition of inflammation of the [[heart]] muscle, and [[pericarditis]] is inflammation of the outer lining of the heart. Myopericarditis is where both occur simultaneously. In all three cases, the body’s immune system causes inflammation in response to an infection or some other trigger. | **Myocarditis** is a condition of inflammation of the [[heart]] muscle, and [[pericarditis]] is inflammation of the outer lining of the heart. Myopericarditis is where both occur simultaneously. In all three cases, the body’s immune system causes inflammation in response to an infection or some other trigger. | ||
- | Increased occurrence | + | ===== Myocarditis in Animals ===== |
+ | Animals other than humans can suffer from myocarditis. | ||
+ | * A strain | ||
- | ===== COVID-19 Pandemic and Vaccines ===== | ||
- | ^ | + | ===== Myocarditis |
- | ^ ^ Age 12 - 17 ^ Age 18 - 24 ^ Male Age < 40 ^ Female Age < 40 ^ Rate from Sars-cov-2 | + | |
- | | Kaiser Permanente Study - Dec 27, 2021((https:// | + | |
- | | Nature Medicine Paper - Dec 25, 2021((https:// | + | |
+ | Myocarditis can be caused by Covid-19 infection as well as a side effect of Covid-19 Vaccination (see also [[covid-19_vaccines: | ||
+ | ==== Florida Surgeon General Warning ==== | ||
+ | Florida Department of Health sent this bulletin at 10/07/2022 06:12 PM EDT | ||
- | ===== Mechanisms | + | {{ :: |
+ | TALLAHASSEE, | ||
- | ===== Pausing Moderna’s | + | This analysis found that there is an 84% increase in the relative incidence of cardiac-related death among males 18-39 years old within 28 days following mRNA vaccination. With a high level of global immunity to COVID-19, the benefit of vaccination is likely outweighed by this abnormally high risk of cardiac-related death among men in this age group. Non-mRNA vaccines were not found to have these increased risks. |
+ | |||
+ | As such, the State Surgeon General recommends against males aged 18 to 39 from receiving mRNA COVID-19 vaccines. Those with preexisting cardiac conditions, such as myocarditis and pericarditis, | ||
+ | |||
+ | “Studying the safety and efficacy of any medications, | ||
+ | |||
+ | |||
+ | === The analysis can be found here === | ||
+ | |||
+ | Exploring the relationship between all-cause and cardiac-related mortality following | ||
+ | |||
+ | Objective - To evaluate the risks of all-cause and cardiac-related mortality following COVID-19 vaccination | ||
+ | ((https:// | ||
+ | |||
+ | |||
+ | === The guidance can be found here === | ||
+ | |||
+ | Guidance for mRNA COVID-19 Vaccines - October 7, 2022 | ||
+ | Florida continues to emphasize that health care providers review all data to evaluate risks and benefits unique to each patient when determining any health care services to provide, including the administration of [[:COVID-19 vaccines]] containing Messenger RNA (mRNA) which both the [[:Pfizer]] - [[: | ||
+ | |||
+ | The Florida Department of Health (Department) conducted an analysis through a self-controlled case series, which is a technique originally developed to evaluate vaccine safety. This studied mortality risk following mRNA COVID-19 vaccination. This analysis found there is an 84% increase in the relative incidence of cardiac-related death among males 18-39 years old within 28 days following mRNA vaccination. Individuals with preexisting cardiac conditions, such as myocarditis and pericarditis, | ||
+ | |||
+ | As such, the Florida Department of Health has issued the following guidance ((https:// | ||
- | On October 6, 2021 Sweden and Denmark said they will pause the use of Moderna’s COVID vaccine for younger age groups after reports of side effects, including myocarditis and pericarditis. Following suit was Finland October 7, Iceland October 8 and France November 8. | ||